Awards as PI
| Funding | ||
|---|---|---|
| Disease Team Therapy Planning I | Phase I study of IM Injection of VEGF Producing MSC for the Treatment of Critical Limb Ischemia | $76,861 |
| Disease Team Therapy Development - Research | Phase I study of IM Injection of VEGF-Producing MSC for the Treatment of Critical Limb Ischemia | $14,184,595 |
Total: $14,261,456.00 |
